Assessment of health-related quality of life in patients with bronchiectasis colonized by Pseudomonas aeruginosa
L. Bueno Freire (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain), L. Fernández Barat (Barcelona, Spain), G. Scioscia (Foggia, Italy), P. Oscanoa (Barcelona, Spain), N. Vázquez (Barcelona, Spain), A. López Gavin (Barcelona, Spain), A. Gabarrús (Barcelona, Spain), R. Amaro (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. López Aladid (Barcelona, Spain), A. Torres (Barcelona, Spain)
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Session: Bronchiectasis and pleural infection
Session type: E-poster
Number: 2017
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bueno Freire (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain), L. Fernández Barat (Barcelona, Spain), G. Scioscia (Foggia, Italy), P. Oscanoa (Barcelona, Spain), N. Vázquez (Barcelona, Spain), A. López Gavin (Barcelona, Spain), A. Gabarrús (Barcelona, Spain), R. Amaro (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. López Aladid (Barcelona, Spain), A. Torres (Barcelona, Spain). Assessment of health-related quality of life in patients with bronchiectasis colonized by Pseudomonas aeruginosa. 2017
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
A single isolation of pseudomonas aeruginosa predicts poor quality of life and increased exacerbation frequency in adult bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015
Assessment of quality of life in patients with bronchiectasis Source: Virtual Congress 2021 – Bronchiectasis Year: 2021
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020
Effects of prophylactic clarithromycin administration on quality of life in non-CF bronchiectasis patients Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Adherence in bronchiectasis (BQ) and concordance between multidimensional scales in a cohort of patients colonized by Pseudomonas aeruginosa (PsA). Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017
Determinants of health-related quality of life in patients with severe COPD Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life Year: 2011
Pseudomonas aeruginosa colonisation in patients without bronchiectasisSource: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014
Influence of biofim on the bronchial microbiome in COPD patients colonized or infected by pseudomonas aeruginosa Source: International Congress 2015 – Advances from translational research in respiratory infections Year: 2015
Prognosis of health-related quality of life in COPD patients and its determinants Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001
Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005
A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Health-related quality of life in non-cystic fibrosis bronchiectasis children Source: Annual Congress 2011 - Rare lung diseases in children Year: 2011
Using SF-36 in assessment of quality of life in patients cured of pulmonary tuberculosis Source: Annual Congress 2011 - Management of tuberculosis Year: 2011
Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020 Year: 2021
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006
Health-related quality of life of patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 16s Year: 2004
The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018
Factors associated with quality of life measured by EQ-5D in Korean COPD patients Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013